Anticonvulsant drugs in bipolar disorder.

Abstract

Although much progress has been made in successfully treating bipolar disorder, there is increasing awareness of the limitations of traditional treatment regimens such as lithium and neuroleptics. The large family of anticonvulsant drugs, however, appears to be capable of providing new treatment options, not only as medication of second choice in patients refractory to treatment, but often as a treatment standard with high efficacy and low incidence of side effects. Besides established mood stabilizers such as carbamazepine and valproate, new antiepileptic drugs are entering the field with promising initial results in the treatment of bipolar patients. Furthermore, bringing to light the mechanisms of action of anticonvulsants and the similarities between anticonvulsants effective in bipolar disorder may also deepen our understanding of the pathophysiological basis of the disorder.

• Authors: H Grunze, S Schlösser, B Amann, J Walden
• Journal: Dialogues in clinical neuroscience (Dialogues Clin Neurosci) Vol. 1 Issue 1 Pg. 24-40 (Jun 1999) ISSN: 1294-8322 [Print] England
• PMID: 22033602 (Publication Type: Journal Article)